# EDGAR Filing Document

**Accession Number:** 0001799207
**File Stem:** 0001999371-25-019236
**Filing Date:** 2025-12
**Character Count:** 19468
**Document Hash:** a60cb43611758a9cc6c124d877eb7e31
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001999371-25-019236.hdr.sgml**: 20251202

**ACCESSION NUMBER**: 0001999371-25-019236

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251202

**DATE AS OF CHANGE**: 20251202

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AUNA S.A.
- **CENTRAL INDEX KEY:** 0001799207
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94489
- **FILM NUMBER:** 251544449

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 6, RUE JEAN MONNET
- **CITY:** GRAND DUCHY OF LUXEMBOURG
- **PROVINCE COUNTRY:** N4
- **ZIP:** L-2180
- **BUSINESS PHONE:** 51 (205-3500)

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 6, RUE JEAN MONNET
- **CITY:** GRAND DUCHY OF LUXEMBOURG
- **PROVINCE COUNTRY:** N4
- **ZIP:** L-2180

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AUNA S.A.A.
- **DATE OF NAME CHANGE:** 20200930

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AUNA S.A.
- **DATE OF NAME CHANGE:** 20200108
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Grupo Angeles Servicios de Salud, S.A. de C.V.
- **CENTRAL INDEX KEY:** 0002019118

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** O5
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** CAMINO A SANTA TERESA 1055, PISO 14
- **STREET 2:** HEROES DE PADIERNA
- **CITY:** LA MAGDALENA CONTREWRAS
- **STATE:** O5
- **ZIP:** 10700
- **BUSINESS PHONE:** 52(55)54497488

**MAIL ADDRESS:**
- **STREET 1:** CAMINO A SANTA TERESA 1055, PISO 14
- **STREET 2:** HEROES DE PADIERNA
- **CITY:** LA MAGDALENA CONTREWRAS
- **STATE:** O5
- **ZIP:** 10700

## Ex-99

**Schedule 1**

The Reporting Persons effected the transactions in Class A Ordinary Shares on the New York Stock Exchange set forth below. The prices below reflect the price paid by the purchasers per Class A Ordinary Shares on the relevant trade date.

---

| | | | |
|:---|:---|:---|:---|
| **Reporting<br> Person** | **Type of<br> Transaction** | **Trade<br> Date** | **Number <br> of Shares** |
| GASS | Sell | 11/14/2025 | 14095$5.15<sup>(1)</sup> |
| GASS | Sell | 11/18/2025 | 997$5.12<sup>(2)</sup> |
| GASS | Sell | 11/21/2025 | 20781$4.72<sup>(3)</sup> |
| GASS | Sell | 11/24/2025 | 60601$4.76<sup>(4)</sup> |
| GASS | Sell | 11/25/2025 | 81098$4.72<sup>(5)</sup> |
| GASS | Sell | 11/26/2025 | 21358$4.72<sup>(6)</sup> |
| GASS | Sell | 11/28/2025 | 122155$4.70<sup>(7)</sup> |
| GASS | Sell | 12/01/2025 | 93130$4.78<sup>(8)</sup> |

---

&nbsp;&nbsp;&nbsp;&nbsp;1. Weighted average price. These shares were sold in multiple transactions
at prices ranging from $5.12 to $5.18 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer,
or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the shares purchased
at each separate price within the range set forth in this footnote. (1).

&nbsp;&nbsp;&nbsp;&nbsp;2. Weighted average price. These shares were sold in multiple transactions
at a price of $5.12. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC,
upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote. (2).

&nbsp;&nbsp;&nbsp;&nbsp;3. Weighted average price. These shares were sold in multiple transactions
at prices ranging from $4.70 to $4.73 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer,
or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth
in this footnote. (3).

&nbsp;&nbsp;&nbsp;&nbsp;4. Weighted average price. These shares were sold in multiple transactions
at prices ranging from $4.72 to $4.88 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer,
or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth
in this footnote (4).

&nbsp;&nbsp;&nbsp;&nbsp;5. Weighted average price. These shares were sold in multiple transactions
at prices ranging from $4.64 to $4.82 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer,
or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth
in this footnote (5).

&nbsp;&nbsp;&nbsp;&nbsp;6. Weighted average price. These shares were sold in multiple transactions
at prices ranging from $4.70 to $4.78 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer,
or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth
in this footnote (6).

&nbsp;&nbsp;&nbsp;&nbsp;7. Weighted average price. These shares were sold in multiple transactions
at prices ranging from $4.63 to $4.80 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer,
or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth
in this footnote (7).

&nbsp;&nbsp;&nbsp;&nbsp;8. Weighted average price. These shares were purchased in multiple transactions
at prices ranging from $4.70 to $4.82 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer,
or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth
in this footnote (8).

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 4)**

**AUNA S.A.**

*(Name of Issuer)*

**Class A Ordinary Shares, nominal value US$0.01 per share**

*(Title of Class of Securities)*

**L0415A103**

*(CUSIP Number)*

**Jose Luis Alberdi Gonzalez**<br>Camino a Santa Teresa 1055, piso 14<br>Heroes de Padierna<br>La Magdalena Contreras O5 10700<br>52 (55) 5449-7488

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**11/28/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **L0415A103** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Grupo Angeles Servicios de Salud, S.A. de C.V.** | Name of reporting person<br>**Grupo Angeles Servicios de Salud, S.A. de C.V.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**O5** | Citizenship or place of organization<br>**O5** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**6346406.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**6346406.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6346406.00** | Aggregate amount beneficially owned by each reporting person<br>**6346406.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**21.09%** | Percent of class represented by amount in Row (11)<br>**21.09%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The percent calculation assumes that there is a total of 30,095,388 Class A Ordinary Shares (as defined below) outstanding as of June 30, 2025, as reported in Exhibit 99.1 to the Report of Foreign Private Issuer on Form 6-K/A furnished by the Issuer (as defined below) to the Securities and Exchange Commission (the "SEC") on October 28, 2025 (the "Form 6-K/A").

| **CUSIP No.** | **L0415A103** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Grupo Vazol, S.A. de C.V. (Priorly known as Grupo Empresarial Angeles, S.A. de C.V.)** | Name of reporting person<br>**Grupo Vazol, S.A. de C.V. (Priorly known as Grupo Empresarial Angeles, S.A. de C.V.)** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**O5** | Citizenship or place of organization<br>**O5** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**6346406.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**6346406.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6346406.00** | Aggregate amount beneficially owned by each reporting person<br>**6346406.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**21.09%** | Percent of class represented by amount in Row (11)<br>**21.09%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

**Comment for Reporting Person:** The percent calculation assumes that there is a total of 30,095,388 Class A Ordinary Shares outstanding as of June 30, 2025, as reported in the Form 6-K/A.

| **CUSIP No.** | **L0415A103** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Corpvaza, S.A. de C.V.** | Name of reporting person<br>**Corpvaza, S.A. de C.V.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**O5** | Citizenship or place of organization<br>**O5** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**6346406.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**6346406.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6346406.00** | Aggregate amount beneficially owned by each reporting person<br>**6346406.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**21.09%** | Percent of class represented by amount in Row (11)<br>**21.09%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

**Comment for Reporting Person:** The percent calculation assumes that there is a total of 30,095,388 Class A Ordinary Shares outstanding as of June 30, 2025, as reported in the Form 6-K/A.

| **CUSIP No.** | **L0415A103** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Mr. Olegario Vazquez Aldir** | Name of reporting person<br>**Mr. Olegario Vazquez Aldir** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**O5** | Citizenship or place of organization<br>**O5** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**6346406.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**6346406.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6346406.00** | Aggregate amount beneficially owned by each reporting person<br>**6346406.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**21.09%** | Percent of class represented by amount in Row (11)<br>**21.09%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** The percent calculation assumes that there is a total of 30,095,388 Class A Ordinary Shares outstanding as of June 30, 2025, as reported in the Form 6-K/A.

**Item 1. Security and Issuer**

**(c) Address of Issuer's Principal Executive Offices:**
6, rue Jean Monnet, Luxembourg, N4, L-2180

Pursuant to Rule 13d-2 of the Securities Exchange Act of 1934, as amended, this Amendment No. 4 (this "Amendment") amends and supplements the Schedule 13D filed by Grupo Angeles Servicios de Salud, S.A. de C.V. ("GASS"), Grupo Vazol, S.A. de C.V. ("Vazol"), Corpvaza, S.A. de. C.V. ("Corpvaza"), and Mr. Olegario Vazquez Aldir ("Mr. Vazquez Aldir", and collectively with GASS, Vazol, and Corpvaza, the "Reporting Persons"), on August 22, 2024 (the "Original Schedule 13D"), and as amended and supplemented by Amendment No. 1 filed on September 12, 2024, Amendment No. 2 filed on January 14, 2025 and Amendment No. 3 filed on November 13, 2025 (the "Schedule 13D"), relating to the Class A Ordinary Shares, nominal value US$0.01 per share (the "Class A Ordinary Shares"), of Auna S.A., a public limited liability company incorporated in Grand Duchy of Luxembourg ("Auna", or the "Issuer"). This Amendment amends the Schedule 13D on behalf of the Reporting Persons to furnish the information set forth herein, and except as set forth below, all Items of the Original Schedule 13D remain unchanged. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The following disclosure assumes there are 30,095,388 Class A Ordinary Shares outstanding as of June 30, 2025, as reported in the Report of Foreign Private Issuer on Form 6-K/A furnished by the Issuer with the SEC on October 28, 2025. Pursuant to Rule 13d-3 under the Act, the Reporting Persons may be deemed to beneficially own 6,346,406 shares of Class A Ordinary Shares, which constitutes approximately 21.09% of the outstanding Class A Ordinary Shares.

**(b)**
The information set forth in rows (7) through (10) of the cover pages of this Schedule 13D is incorporated by reference into this Item 5(b).

**(c)**
All transactions in Class A Ordinary Shares effected by the Reporting Persons and, to the best knowledge of the Reporting Persons, the Covered Persons since the filing of Amendment No. 3 for which disclosure is required by Schedule 13D are listed in Schedule 1 hereto and incorporated herein by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Grupo Angeles Servicios de Salud, S.A. de C.V.

**Signature:** /s/ Jose Luis Alberdi Gonzalez

**Name/Title:** Jose Luis Alberdi Gonzalez/Legal Vice President

**Date:** 12/02/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Grupo Vazol, S.A. de C.V. (Priorly known as Grupo Empresarial Angeles, S.A. de C.V.)

**Signature:** /s/ Jose Luis Alberdi Gonzalez

**Name/Title:** Jose Luis Alberdi Gonzalez/Legal Vice President

**Date:** 12/02/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Corpvaza, S.A. de C.V.

**Signature:** /s/ Jose Luis Alberdi Gonzalez

**Name/Title:** Jose Luis Alberdi Gonzalez/Legal Vice President

**Date:** 12/02/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Mr. Olegario Vazquez Aldir

**Signature:** /s/ Jose Luis Alberdi Gonzalez

**Name/Title:** Jose Luis Alberdi Gonzalez/Legal Vice President

**Date:** 12/02/2025